Table 5 Aggregate results of the Working Group 3 and Working Group 4 and comparison of differences between the stakeholder groups
From: Evaluation of dialysis centres: values and criteria of the stakeholders
Patients | Clinicians | Managers | Patients/ Clinicians | Patients/ Managers | Clinicians/ Managers | ||
|---|---|---|---|---|---|---|---|
(n = 25) | (n = 33) | (n = 27) | |||||
Mean (SD) | Mean (SD) | Mean (SD) | P-value | P-value | P-value | ||
Criteria | Sub-criteria | ||||||
Evidence-based variables | 24.00 (8.16) | 24.91 (9.53) | 25.11 (10.34) | 1.000 | 1.000 | 1.000 | |
Type of vascular access | 29 .00 (9.01) | 27.66 (7.32) | 28.70 (8.03) | 1.000 | 1.000 | 1.000 | |
Dialysis dose | 23.52 (8.12) | 23.84 (5.83) | 22.03 (6.24) | 1.000 | 1.000 | 0.903 | |
Haemoglobin concentration | 15.64 (4.85) | 16.24 (3.79) | 15.74 (3.31) | 1.000 | 1.000 | 1.000 | |
Ratio of bacteraemia related to the catheter | 17.00 (8.66) | 20.60 (5.57) | 22.77 (5.60) | 0.131 | 0.007* | 0.633 | |
Mineral and bone disease | 14.84 (6.75) | 11.63 (5.52) | 10.74 (4.94) | 0.116 | 0.036* | 1.000 | |
Morbidity, annual | 15.00 (8.16) | 17.42 (5.60) | 19.70 (6.82) | 0.551 | 0.045* | 0.604 | |
Mortality, annual | 13.40 (7.03) | 15.63 (6.09) | 17.48 (8.51) | 0.735 | 0.133 | 0.98 | |
PROMs | 29.4 (7.68) | 24.54 (6.54) | 24.15 (7.81) | 0.042* | 0.034* | 1.000 | |
PREMs | 18.20 (8.89) | 17.48 (5.75) | 13.18 (4.86) | 1.000 | 0.023* | 0.042* | |